Trials / Completed
CompletedNCT01897753
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone (Gh) Treatment On Height Gain In Children Born Small for Gestational Age (SGA)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | growth hormone | 36 months |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2013-07-12
- Last updated
- 2014-01-20
Locations
12 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01897753. Inclusion in this directory is not an endorsement.